계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
BlueWillow Biologics
company
About
BlueWillow is a biopharmaceutical company that focuses on developing and commercializing topical antiseptic and anti-infective products.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Health Care,Medical,Nanotechnology
- Founded date
- Jan 1, 2000
- Number Of Employee
- 11 - 50
- Operating Status
- Active
BlueWillow Biologics operates as a clinical-stage, privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin and nose.The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
BlueWillow Biologics has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
May 7, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 7, 2018 | Series A | $10M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
BlueWillow Biologics is funded by 2 investors.
Line Moon Ventures
and University of Michigan MINTS fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
